- Home
- JYNT vs CMPX Comparison
JYNT vs CMPX Comparison
Compare JYNT & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JYNT
- CMPX
- Stock Information
- Founded
- JYNT 2010
- CMPX 2014
- Country
- JYNT United States
- CMPX United States
- Employees
- JYNT N/A
- CMPX N/A
- Industry
- JYNT Multi-Sector Companies
- CMPX Biotechnology: Pharmaceutical Preparations
- Sector
- JYNT Miscellaneous
- CMPX Health Care
- Exchange
- JYNT Nasdaq
- CMPX Nasdaq
- Market Cap
- JYNT 170.3M
- CMPX 291.8M
- IPO Year
- JYNT 2014
- CMPX N/A
- Fundamental
- Price
- JYNT $10.03
- CMPX $3.61
- Analyst Decision
- JYNT Strong Buy
- CMPX Strong Buy
- Analyst Count
- JYNT 3
- CMPX 8
- Target Price
- JYNT $16.33
- CMPX $13.50
- AVG Volume (30 Days)
- JYNT 80.9K
- CMPX 978.5K
- Earning Date
- JYNT 11-06-2025
- CMPX 11-11-2025
- Dividend Yield
- JYNT N/A
- CMPX N/A
- EPS Growth
- JYNT N/A
- CMPX N/A
- EPS
- JYNT N/A
- CMPX N/A
- Revenue
- JYNT $53,449,713.00
- CMPX N/A
- Revenue This Year
- JYNT $8.06
- CMPX N/A
- Revenue Next Year
- JYNT $11.18
- CMPX N/A
- P/E Ratio
- JYNT N/A
- CMPX N/A
- Revenue Growth
- JYNT 277.36
- CMPX N/A
- 52 Week Low
- JYNT $9.58
- CMPX $1.27
- 52 Week High
- JYNT $13.47
- CMPX $4.08
- Technical
- Relative Strength Index (RSI)
- JYNT 33.53
- CMPX 64.52
- Support Level
- JYNT $9.85
- CMPX $3.37
- Resistance Level
- JYNT $10.74
- CMPX $3.77
- Average True Range (ATR)
- JYNT 0.20
- CMPX 0.19
- MACD
- JYNT -0.05
- CMPX 0.01
- Stochastic Oscillator
- JYNT 21.98
- CMPX 64.58
About JYNT The Joint Corp.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has one operating business segment; The Franchise Operations segment which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the Company's franchise license, which represents symbolic intellectual property.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.